<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Kenta Masuda | Yau Research Group</title>
    <link>http://localhost:1313/author/kenta-masuda/</link>
      <atom:link href="http://localhost:1313/author/kenta-masuda/index.xml" rel="self" type="application/rss+xml" />
    <description>Kenta Masuda</description>
    <generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Sat, 01 Jan 2022 00:00:00 +0000</lastBuildDate>
    <image>
      <url>http://localhost:1313/media/icon_hu_7613a4a452ac7087.png</url>
      <title>Kenta Masuda</title>
      <link>http://localhost:1313/author/kenta-masuda/</link>
    </image>
    
    <item>
      <title>Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation</title>
      <link>http://localhost:1313/publication/zheng-2022-author/</link>
      <pubDate>Sat, 01 Jan 2022 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/publication/zheng-2022-author/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation (vol 9, 476, 2018)</title>
      <link>http://localhost:1313/publication/zheng-2022-tuning/</link>
      <pubDate>Sat, 01 Jan 2022 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/publication/zheng-2022-tuning/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells</title>
      <link>http://localhost:1313/publication/artibani-2021-adipocyte/</link>
      <pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/publication/artibani-2021-adipocyte/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation</title>
      <link>http://localhost:1313/publication/zheng-2018-tuning/</link>
      <pubDate>Mon, 01 Jan 2018 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/publication/zheng-2018-tuning/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
